@shyaam1996
Slow down buddy...
Sarepta's Exondys51 is mRNA technology not Gene Therapy - and is only applicable to 13% of DMD ambulant boys. Currently raking in ~US$500m in annual revenue.
Exondys51 did receive early FDA approval - without any meaningful efficacy - no PUL 2 or MyoGrip..or MRI showing FF%. It targets dystrophin production, not inflammation...the additional dystrophin was considered beneficial. It got approved on the back of PPMD support in the US as there is no viable alternative apart from Corticosteroids.
Sraepta's Gene Therapy program delivered terrible results in January 2021 - no efficacy data, and the FDA has since taken a more cautious approach to all Gene Therapies across all indications due to safety issues (vectors).
ANP are targeting 100% of DMD boys - ambulant and non-ambulant.
Most importantly - ATL1102 has shown efficacy at P2a stage - across multiple measures...PUL2, Myogrip, Fat Fraction % reduction.
If ANP can replicate the P2a results in the EMA trial over 12 months - then we are set for early approval in Europe.
Highly recommend all new-comers read threads from major results anns - also the presos on the website going back to P2 start...
.
- Forums
- ASX - By Stock
- PER
- Comparison Capricor vs. ANP
Comparison Capricor vs. ANP, page-24
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.8¢ |
Change
-0.002(2.50%) |
Mkt cap ! $70.32M |
Open | High | Low | Value | Volume |
7.6¢ | 7.8¢ | 7.5¢ | $32.58K | 429.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 253224 | 7.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 253231 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 253224 | 0.075 |
3 | 360708 | 0.074 |
1 | 100000 | 0.072 |
2 | 310000 | 0.071 |
7 | 58616 | 0.070 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 253231 | 2 |
0.081 | 100000 | 1 |
0.082 | 255785 | 2 |
0.083 | 110520 | 2 |
0.084 | 57142 | 1 |
Last trade - 14.56pm 22/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |